Efficacy and safety of intradermal vaccination against porcine circovirus type 2 and Mycoplasma hyopneumoniae under combined exposure field conditions

被引:0
作者
Tassis, Panagiotis [1 ]
Pel, Suzanne [2 ]
Floros, Dimitrios [1 ]
ter Haar, Kim [2 ]
Cao, Qi [2 ]
Tsakmakidis, Ioannis [1 ]
Papatsiros, Vassileios [3 ]
Ntarampa, Niki [1 ]
Arsenakis, Ioannis [4 ]
Tzika, Eleni D. [1 ]
机构
[1] Aristotle Univ Thessaloniki, Sch Vet Med, Farm Anim Clin, Thessaloniki, Greece
[2] MSD Anim Hlth, Boxmeer, Netherlands
[3] Univ Thessaly, Sch Vet Med, Clin Med, Kardhitsa, Greece
[4] Agr Univ Athens, Lab Anat & Physiol Farm Anim, Athens, Greece
关键词
Pigs; Intradermal vaccination; Porcine circovirus type 2; Mycoplasma hyopneumoniae; Lung lesions; Pleurisy; Viraemia; Enzootic pneumonia; Porcine respiratory disease complex; PIGS; INFECTION; UNIFORMITY; DISEASE; WEIGHT; PCV2;
D O I
10.1186/s40813-025-00431-y
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background Porcine circovirus 2 (PCV2) and Mycoplasma hyopneumoniae (M hyo) are two of the most important swine pathogens with variable clinical presence in swine farms globally, affecting health and performance of pigs under field conditions. The primary objective of this study was to assess the efficacy of a ready to use intradermal (ID) vaccine (Porcilis PCV M Hyo ID, MSD Animal Health, The Netherlands) against PCV2 associated disease and M hyo associated enzootic pneumonia under practical (field) conditions. In addition, the safety of the test product was clinically assessed, as the study animals were examined for general and local side effects after vaccination. A total of 678 animals in a Greek farrow to finish farm were equally divided in two trial groups (test and control group). Test group animals received the test vaccine at the age of three weeks, while control group animals remained unvaccinated. Parameters regarding health [lung lesion score (LLS) and pleurisy scoring, PCV2 viraemia and shedding] and performance [body weight (BW), average daily weight gain (ADWG)] were recorded and evaluated. Results Vaccination improved the ADWG during both the finishing period (improvement by 34 g; p < 0.0001), and the overall period (increase by 24 g; p < 0.0001). Moreover, reduced mean LLS values (p < 0.0001), as well as reduced percentage of animals with pleurisy (p = 0.0082) and a decrease in PCV2 viraemia (p < 0.0001) and viral shedding (p = 0.0181) were observed in vaccinated animals when compared with the unvaccinated controls. As regards safety, a slight local skin reaction at the site of vaccination was detected and in two pigs a mild systemic reaction was reported with full recovery. Conclusions Findings suggested that the test vaccine is safe and effective against both PCV2 and M hyo associated diseases in vivo, thus it's use as part of a vaccination programme under field conditions is expected to improve respective health and performance parameters in pigs.
引用
收藏
页数:12
相关论文
共 50 条
[31]   A new single-dose bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae elicits protective immunity and improves growth performance under field conditions [J].
Jeong, Jiwoon ;
Park, Changhoon ;
Choi, Kyuhyung ;
Chae, Chanhee .
VETERINARY MICROBIOLOGY, 2016, 182 :178-186
[32]   A field efficacy and safety trial in the Netherlands in pigs vaccinated at 3 weeks of age with a ready-to-use porcine circovirus type 2 and Mycoplasma hyopneumoniae combined vaccine [J].
Luuk Kaalberg ;
Victor Geurts ;
Rika Jolie .
Porcine Health Management, 3
[33]   Efficacy of Two Commercial Ready-To-Use PCV2 and Mycoplasma hyopneumoniae Vaccines under Field Conditions [J].
Lopez-Lorenzo, Gonzalo ;
Prieto, Alberto ;
Lopez-Novo, Cynthia ;
Diaz, Pablo ;
Lopez, Ceferino Manuel ;
Morrondo, Patrocinio ;
Fernandez, Gonzalo ;
Diaz-Cao, Jose Manuel .
ANIMALS, 2021, 11 (06)
[34]   The Evaluation of a Porcine Circovirus Type 2 (PCV2) Intradermal Vaccine Against a PCV2 Field Strain [J].
Hsieh, Cheng-Kai ;
Chien, Chia-Yi ;
Liu, Chun-Wei ;
Chang, Shu-Wei ;
Lin, Hongyao ;
Ellerma, Leonardo ;
Chiou, Ming-Tang ;
Lin, Chao-Nan .
VACCINES, 2025, 13 (04)
[35]   Efficacy comparison of commercial porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae monovalent and bivalent vaccines against a dual challenge [J].
Yang, Siyeon ;
Park, Su-Jin ;
Oh, Taehwan ;
Cho, Hyejean ;
Chae, Chanhee .
CANADIAN JOURNAL OF VETERINARY RESEARCH-REVUE CANADIENNE DE RECHERCHE VETERINAIRE, 2020, 84 (04) :272-282
[36]   Evaluation of porcine circovirus type 2 double vaccination in weaning piglets that reared for gilts under field conditions [J].
Papatsiros, Vasileios ;
Papakonstantinou, Georgios ;
Meletis, Eleftherios ;
Bitchava, Dimitra ;
Kostoulas, Polychronis .
VETERINARY RESEARCH FORUM, 2023, 14 (01) :13-19
[37]   Efficacy of a new ready-to-use vaccine against PCV-2d and Mycoplasma hyopneumoniae under experimental conditions [J].
Krejci, Roman ;
Trampus, Peter ;
Csagola, Attila ;
Szalai, Tamas ;
Palmai, Mimrod ;
Toth, Adam ;
Terenyi, Mora ;
Magy, Zoltan ;
Szeplaki, Mikoletta-Agnes ;
Somogyi, Ger Gely ;
Barna, Timea ;
Rausch, Eniko ;
Penzes, Zoltan ;
Szaszko, Maria ;
Lorincz, Zsolt .
VETERINARNI MEDICINA, 2025, 70 (06) :196-202
[38]   Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2 [J].
Kim, D. ;
Kim, C. H. ;
Han, K. ;
Seo, H. W. ;
Oh, Y. ;
Park, C. ;
Kang, I. ;
Chae, C. .
VACCINE, 2011, 29 (17) :3206-3212
[39]   The effects of Mycoplasma hyopneumoniae on porcine circovirus type 2 replication in vitro PK-15 cells [J].
Wang, Haiyan ;
Feng, Zhixin ;
Wu, Yuzi ;
Wei, Yanna ;
Gan, Yuan ;
Hua, Lizhong ;
Li, Bin ;
Wang, Xiaomin ;
Liu, Maojun ;
Xiong, Qiyan ;
Shao, Guoqing .
RESEARCH IN VETERINARY SCIENCE, 2016, 105 :56-61
[40]   Non-Compromised Efficacy of the First Commercial Ready-to-Use Genotype 2d Porcine Circovirus Type 2 and Mycoplasma hyopneumoniae Vaccine [J].
Palmai, Nimrod ;
Szeplaki, Nikoletta-Agnes ;
Molnar, Balint ;
Smits, Han ;
Krejci, Roman ;
Kiss, Istvan .
VIRUSES-BASEL, 2025, 17 (04)